| Literature DB >> 31221685 |
Sucharita Ray1, Neeraj Balaini1, Kamalesh Chakravarty2, Shivnarayan Pattanayak1, Abeer Goel1, Aastha Takkar1, Vivek Lal1.
Abstract
Aspergillus is a rare but important opportunistic pathogen to invade the central nervous system (CNS). It is a significant pathogen of not only immunocompromised but also immunocompetent patients. Its manifestations are pleiotropic, reflecting multiple mechanisms of pathogenesis and host interactions. Despite significant advances in diagnostic methods and therapeutic options, the mortality remains high. Several advances have been made in medications and surgical management, yet, current treatment practices lack uniformity. Patient woes are further heightened by the high costs of treatment and prolonged duration of therapy. In view of the challenging aspects of this disease, we present a short review of four challenging cases touching on the varied aspects of management of CNS aspergillosis covering pathogenesis, diagnostic pitfalls, surgical and medical options and evidence-based guidelines for the management of the same. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: CNS aspergillosis; amphotericin; antifungal; aspergillosis; debridement; debulking surgery; epitope; nitrogen cycling; pathogen; pathogenesis; rhinocerebral; voriconazole
Mesh:
Substances:
Year: 2019 PMID: 31221685 DOI: 10.1136/postgradmedj-2018-136095
Source DB: PubMed Journal: Postgrad Med J ISSN: 0032-5473 Impact factor: 2.401